97 related articles for article (PubMed ID: 33045974)
1. Studying the Anti-Tumor Effects of siRNA Gene Silencing of Some Metabolic Genes in Pancreatic Ductal Adenocarcinoma.
Al Hanjori AS; Alshaer W; Al-Anati B; Wehaibi S; Zihlif M
Curr Mol Pharmacol; 2021 Oct; 14(4):604-619. PubMed ID: 33045974
[TBL] [Abstract][Full Text] [Related]
2. A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression.
Zhao X; Li DC; Zhao H; Li Z; Wang JX; Zhu DM; Zhou J; Cen JN
Oncol Rep; 2012 Mar; 27(3):628-36. PubMed ID: 22200682
[TBL] [Abstract][Full Text] [Related]
3. Effects of alphavbeta6 gene silencing by RNA interference in PANC-1 pancreatic carcinoma cells.
Niu W; Liu X; Zhang Z; Xu K; Chen R; Liu E; Wang J; Peng C; Niu J
Anticancer Res; 2010 Jan; 30(1):135-42. PubMed ID: 20150628
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia-inducible factor-1 up-regulates the expression of Toll-like receptor 4 in pancreatic cancer cells under hypoxic conditions.
Fan P; Zhang JJ; Wang B; Wu HQ; Zhou SX; Wang CY; Zhang JH; Tian Y; Wu HS
Pancreatology; 2012; 12(2):170-8. PubMed ID: 22487528
[TBL] [Abstract][Full Text] [Related]
5. miR-124 Suppresses Pancreatic Ductal Adenocarcinoma Growth by Regulating Monocarboxylate Transporter 1-Mediated Cancer Lactate Metabolism.
Wu DH; Liang H; Lu SN; Wang H; Su ZL; Zhang L; Ma JQ; Guo M; Tai S; Yu S
Cell Physiol Biochem; 2018; 50(3):924-935. PubMed ID: 30355947
[TBL] [Abstract][Full Text] [Related]
6. Identification of thioredoxin-interacting protein 1 as a hypoxia-inducible factor 1alpha-induced gene in pancreatic cancer.
Baker AF; Koh MY; Williams RR; James B; Wang H; Tate WR; Gallegos A; Von Hoff DD; Han H; Powis G
Pancreas; 2008 Mar; 36(2):178-86. PubMed ID: 18376310
[TBL] [Abstract][Full Text] [Related]
7. Functional metabolic screen identifies 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 as an important regulator of prostate cancer cell survival.
Ros S; Santos CR; Moco S; Baenke F; Kelly G; Howell M; Zamboni N; Schulze A
Cancer Discov; 2012 Apr; 2(4):328-43. PubMed ID: 22576210
[TBL] [Abstract][Full Text] [Related]
8. Effects of the silencing of hypoxia-inducible Factor-1 alpha on metastasis of pancreatic cancer.
Wei H; Li F; Fu P; Liu X
Eur Rev Med Pharmacol Sci; 2013 Feb; 17(4):436-46. PubMed ID: 23467940
[TBL] [Abstract][Full Text] [Related]
9. Small interfering RNAs targeting mutant K-ras inhibit human pancreatic carcinoma cells growth in vitro and in vivo.
Zhu H; Liang ZY; Ren XY; Liu TH
Cancer Biol Ther; 2006 Dec; 5(12):1693-8. PubMed ID: 17106254
[TBL] [Abstract][Full Text] [Related]
10. HIF-2α dictates the susceptibility of pancreatic cancer cells to TRAIL by regulating survivin expression.
Harashima N; Takenaga K; Akimoto M; Harada M
Oncotarget; 2017 Jun; 8(26):42887-42900. PubMed ID: 28476028
[TBL] [Abstract][Full Text] [Related]
11. Decreased expression of MUC1 induces apoptosis and inhibits migration in pancreatic cancer PANC-1 cells via regulation of Slug pathway.
Zhao P; Meng M; Xu B; Dong A; Ni G; Lu L
Cancer Biomark; 2017 Dec; 20(4):469-476. PubMed ID: 28869438
[TBL] [Abstract][Full Text] [Related]
12. Wilms' tumour gene 1 (WT1) as a target in curcumin treatment of pancreatic cancer cells.
Glienke W; Maute L; Wicht J; Bergmann L
Eur J Cancer; 2009 Mar; 45(5):874-80. PubMed ID: 19196508
[TBL] [Abstract][Full Text] [Related]
13. Effect of small interference RNA targeting HIF-1alpha mediated by rAAV combined L: -ascorbate on pancreatic tumors in athymic mice.
Chen C; Sun J; Liu G; Chen J
Pathol Oncol Res; 2009 Mar; 15(1):109-14. PubMed ID: 18509748
[TBL] [Abstract][Full Text] [Related]
14. A Light-Driven Therapy of Pancreatic Adenocarcinoma Using Gold Nanorods-Based Nanocarriers for Co-Delivery of Doxorubicin and siRNA.
Yin F; Yang C; Wang Q; Zeng S; Hu R; Lin G; Tian J; Hu S; Lan RF; Yoon HS; Lu F; Wang K; Yong KT
Theranostics; 2015; 5(8):818-33. PubMed ID: 26000055
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic delivery of siRNA silencing HIF-1 alpha with micellar nanoparticles inhibits hypoxic tumor growth.
Liu XQ; Xiong MH; Shu XT; Tang RZ; Wang J
Mol Pharm; 2012 Oct; 9(10):2863-74. PubMed ID: 22924580
[TBL] [Abstract][Full Text] [Related]
16. PFKFB2 regulates glycolysis and proliferation in pancreatic cancer cells.
Ozcan SC; Sarioglu A; Altunok TH; Akkoc A; Guzel S; Guler S; Imbert-Fernandez Y; Muchut RJ; Iglesias AA; Gurpinar Y; Clem AL; Chesney JA; Yalcin A
Mol Cell Biochem; 2020 Jul; 470(1-2):115-129. PubMed ID: 32415418
[TBL] [Abstract][Full Text] [Related]
17. Effect of small interfering RNA targeting hypoxia-inducible factor-1α on radiosensitivity of PC3 cell line.
Huang Y; Yu J; Yan C; Hou J; Pu J; Zhang G; Fu Z; Wang X
Urology; 2012 Mar; 79(3):744.e17-24. PubMed ID: 22196409
[TBL] [Abstract][Full Text] [Related]
18. Suppression of the Epidermal Growth Factor-like Domain 7 and Inhibition of Migration and Epithelial-Mesenchymal Transition in Human Pancreatic Cancer PANC-1 Cells.
Wang YL; Dong FL; Yang J; Li Z; Zhi QM; Zhao X; Yang Y; Li DC; Shen XC; Zhou J
Asian Pac J Cancer Prev; 2015; 16(9):4065-9. PubMed ID: 25987088
[TBL] [Abstract][Full Text] [Related]
19. Effects of hypoxia-inducible factor-1α silencing on the proliferation of CBRH-7919 hepatoma cells.
Xu LF; Ni JY; Sun HL; Chen YT; Wu YD
World J Gastroenterol; 2013 Mar; 19(11):1749-59. PubMed ID: 23555163
[TBL] [Abstract][Full Text] [Related]
20. Reversal of the phenotype by K-rasval12 silencing mediated by adenovirus-delivered siRNA in human pancreatic cancer cell line Panc-1.
Chen LM; Le HY; Qin RY; Kumar M; Du ZY; Xia RJ; Deng J
World J Gastroenterol; 2005 Feb; 11(6):831-8. PubMed ID: 15682475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
